FundRx
Venture capitalPalo Alto · Pre-Seed–Seed
Investment thesis
FundRx invests in early-stage companies advancing deep health innovation across multiple therapeutic and diagnostic domains. The firm's portfolio spans synthetic biology, AI-driven drug discovery and clinical workflows, novel therapeutics including psychedelics and novel formulations, reproductive health, preventive medicine, and health infrastructure solutions. The investment thesis prioritizes scientific rigor and the potential to meaningfully improve health outcomes at scale, particularly in areas addressing unmet medical needs and health equity gaps.
Source: firm website, verified Aug 6, 2026.
Founder mafia
2 people who came through FundRx went on to found or lead other companies.
What they invest in
from 4 of 5 portfolio companiesAI & Machine Learning ×2Biotech ×2Healthtech ×2Digital Health ×1Fintech ×1Hardware ×1Medical Devices ×1SaaS ×1
HQs:United States×3
Investments · 5 tracked
founders shown can be your intro pathBuoy provides an embedded finance API for working capital and liquidity management, letting treasury managers request on-demand top-ups when prefunding accounts run low.
FintechSaaS
Dan Kleinbaum(CEO)
Co-investorsTimon CapitalF-Prime CapitalHumanaOptum VenturesTrustbridge PartnersWR Hambrecht
Buoy Health offers an AI-based symptom checker that asks users questions to help identify possible health issues and guides them toward appropriate care, products, or providers.
AI & Machine LearningDigital HealthHealthtechBoston, US
Andrew Le(Executive Officer, Director, Promoter)inAndrew Le, MD(Founder)inAdam Lathram(Executive Officer, Director, Promoter)Jose Eduardo Reyes(Director)Nathanael Yu Ren(Director)
Co-investorsEvolution VC PartnersF-Prime CapitalTorch CapitalHumanaOptum VenturesTrustbridge Partners+1 more
BiotechSan Francisco, US
Martin Moore(Executive Officer, Director, Promoter)Roderick Tang(Executive Officer, Director, Promoter)in
NMTC develops neurotechnology combining medical devices and artificial intelligence, supported by scientific and AI advisory boards.
AI & Machine LearningBiotechHardwareHealthtechMedical DevicesEden Prairie, US
Dave Rosa(President & Chief Executive Officer)inDavid Wambecke(Chief Business Officer)Chris Volker(Chief Financial Officer)inSteve Mertens(Chief Technology Officer)inEmily Johns(Chief Administrative Officer & General Counsel)inCamilo Diaz-Botia(Vice President of Engineering)in
Osmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
Co-investorsFelicis VenturesFigure 8 InvestmentsGreycroftMaryland TEDCOMichelson 20MM FoundationSocial Starts+1 more
Portfolio news
latest coverage across their companiesNeuroOne · investing.com · Aug 13, 2026
Osmosis · osmosisim.com · Feb 23, 2026
Frequently asked questions
- What stage does FundRx invest at?
- FundRx invests at the Pre-Seed, Seed stages.
- What sectors does FundRx focus on?
- FundRx focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Where is FundRx located?
- FundRx is headquartered in Palo Alto, US.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Pillar VC is an early-stage venture capital firm that partners with technical founders at the inception stage to build technology companies.
Asia2G (A2G) Capital is a Silicon Valley venture capital firm that invests primarily in early-stage Korean and Asian technology startups seeking to expand globally.